뇌척수액 생물표지자 양성/베타아밀로이드양성자단층촬영 음성 조기발병 알츠하이머병 치매의 추적 관찰
Longitudinal Observation of Early-Onset Alzheimer’s Disease Dementia with Positive CSF Biomarkers/Negative Amyloid-β Positron-Emission Tomography
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We report a 61-year-old woman with clinical course for Alzheimer’s disease (AD) dementia and discordant amyloid-β positron-emission tomography (PET) and cerebrospinal fluid biomarkers. Brain magnetic resonance imaging revealed remarkable atrophy in the hippocampus. However, repeated delayed 18F-flutemetamol brain amyloid PET images with 1 year-interval revealed no amyloid deposition, whereas her CSF revealed low Aβ42, high total tau and p-tau181. This discordant amyloid-β PET and CSF biomarkers in this early-onset AD dementia might be associated with her low resilience or mixed pathology.
Abstract
We report a 61-year-old woman with clinical course for Alzheimer’s disease (AD) dementia and discordant amyloid-β positron-emission tomography (PET) and cerebrospinal fluid biomarkers. Brain magnetic resonance imaging revealed remarkable atrophy in the hippocampus. However, repeated delayed 18F-flutemetamol brain amyloid PET images with 1 year-interval revealed no amyloid deposition, whereas her CSF revealed low Aβ42, high total tau and p-tau181. This discordant amyloid-β PET and CSF biomarkers in this early-onset AD dementia might be associated with her low resilience or mixed pathology.
참고문헌 (10)
- McKhann GM, "The diagnosis of dementia due to Alzheimer's disease:recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease", Alzheimers Dement, 7, pp.263~269 (2011)
- Shea YF, "Impact of amyloid PET Imaging in the memory clinic: a systematic review and meta-analysis", J Alzheimers Dis, 64, pp.323~335 (2018)
- Mattsson N, "Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease", Brain, 138(Pt 3), pp.772~783 (2015)
- -florbetaben PET acquisition in clinical routine cases, "Neuroimage Clin", 2017, 77~86
- florbetaben PET studies, "EJNMMI Res", 2019, 32~
- Park SA, "Cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease in South Korea", Alzheimer Dis Assoc Disord, 31, pp.13~18 (2017)
- Jack CR Jr, "NIA-AA research framework: toward a biological definition of alzheimer's disease", Alzheimers Dement, 14, pp.535~562 (2018)
- Schöll M, "Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers", Neurology, 79, pp.229~236 (2012)
- DeTure MA, "The neuropathological diagnosis of Alzheimer's disease", Mol Neurodegener, 14, pp.32~ (2019)
- Whitwell JL, "Frontal asymmetry in behavioral variant frontotemporal dementia:clinicoimaging and pathogenetic correlates", Neurobiol Aging, 34, pp.636~639 (2013)